Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

SHA:603351 Revenue

Nanjing Well Pharmaceutical Group had revenue of 349.73M CNY in the quarter ending March 31, 2025, with 6.03% growth. This brings the company's revenue in the last twelve months to 1.32B, up 6.25% year-over-year. In the year 2024, Nanjing Well Pharmaceutical Group had annual revenue of 1.30B with 12.19% growth.

• Revenue (ttm): 1.32B
• Revenue Growth: +6.25%
• P/S Ratio: 3.06
• Revenue / Employee: 1.96M
• Employees: 673
• Market Cap: 4.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.30B	140.91M	12.19%
Dec 31, 2023	1.16B	44.83M	4.03%
Dec 31, 2022	1.11B	68.70M	6.59%
Dec 31, 2021	1.04B	306.24M	41.61%
Dec 31, 2020	736.06M	-144.69M	-16.43%